Intec Pharma Ltd. | Ownership
Companies that own Intec Pharma Ltd.
Acuta Capital Partners LLC
2,724,283
8.19%
0
1.92%
12/31/2017
venBio Select Advisor LLC
2,195,705
6.61%
2,195,705
0.3%
12/31/2017
Meitav DS Provident & Pension Ltd.
1,873,294
5.64%
1,707,913
1.4%
12/31/2017
Adage Capital Management LP
1,725,000
5.19%
1,725,000
0.02%
08/16/2017
Prosight Management LP
1,125,153
3.39%
1,125,153
3.11%
06/30/2018
Cormorant Asset Management LP
809,804
2.44%
9,804
0.23%
12/31/2016
Sectoral Asset Management, Inc.
801,252
2.41%
0
0.32%
05/31/2018
Ayalim Mutual Funds Ltd.
753,159
2.27%
-98,618
25.78%
08/04/2017
Harel-Pia Mutual Funds Ltd.
733,116
2.21%
-10,407
0.13%
06/28/2018
Migdal Makefet Pension & Provident Funds Ltd.
602,936
1.82%
602,936
0.14%
04/09/2017
| Address |
RMPE Building
Jerusalem JM 9777512
Israel
|
|
Employees
|
- |
| Website |
http://www.intecpharma.com |
| Updated |
07/08/2019 |
| Intec Pharma Ltd. is a clinical-stage biopharmaceutical company, which focuses on developing drugs based on its proprietary Accordion Pill platform technology. Its product pipeline includes four product candidates in clinical trial stages: Accordion Pill Carbidopa/Levodopa, which is being developed for the treatment of Parkinson's disease symptoms in advanced Parkinson's disease patients; Accordion Pill Zaleplon, which is being developed for the treatment of insomnia, including sleep induction and the improvement of sleep maintenance; an Accordion Pill that is being developed for the prevention and treatment of gastroduodenal and small bowel Nonsteroidal Anti-Inflammatory Drug which induces ulcers; and AP-CBD/THC, an Accordion Pill with the two primary cannabinoids contained in Cannabis sativa, cannabidiol and tetrahydrocannabinol, which is being developed for various indications including low back neuropathic pain and fibromyalgia. The company was founded by Zvi Joseph in 2000 and is headquartered in Jerusalem, Israel. |
